Motor fluctuations in Parkinson's disease: pathophysiology and treatment
- 1 January 1999
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 6 (1) , 1-21
- https://doi.org/10.1046/j.1468-1331.1999.610001.x
Abstract
At the initial stages of Parkinson's disease (PD), levodopa (LD) is able to reduce most motor symptoms and to significantly improve the patient's quality of life. However, in the vast majority of pat...Keywords
This publication has 178 references indexed in Scilit:
- Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuationsNeurology, 1996
- Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Effect of GPi pallidotomy on motor function in Parkinson's diseaseThe Lancet, 1995
- Acute Administration of Levodopa-Benserazide and Tolcapone, a COMT Inhibitor, in Parkinsonʼs DiseaseClinical Neuropharmacology, 1995
- Pergolide: A dopamine agonist at both D1 and D2 receptorsLife Sciences, 1991
- PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic systemJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- Adverse Effects of Antiparkinsonian DrugsDrugs, 1981
- Dopamine receptors in the parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Apomorphine in huntington's chorea: Clinical observations and theoretical considerationsLife Sciences, 1974